G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
Rapamycin-Eluting Stents in the Arterial Duct Experimental Observations in the Pig Model
Kyong-Jin Lee,Aleksander Hinek,Rajiv Chaturvedi,Claudia L. Almeida,Osami Honjo,Gideon Koren,Leland N. Benson +6 more
TL;DR: Rapamycin has antiproliferative actions on the arterial duct and may be a more efficient tool than current palliative options for maintaining patency in critically duct-dependent states, but there might be a finite time-related benefit.
Journal Article
The Digoxin-Propafenone Interaction: Characterization of a Mechanism Using Renal Tubular Cell Monolayers
TL;DR: The data suggest that propafenone is an inhibitor of P-glycoprotein, whereas 5-OHP is a possible substrate, which is consistent with the hypothesis that the digoxin-propafen one interaction results from the inhibition of the renal tubular transport of digoxin by propafinone and its metabolites.
Journal ArticleDOI
The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: a twin study.
TL;DR: Given that twins are theoretically exposed to similar maternal drug levels, the findings suggest that the placenta may have a major role in modulating the amounts of drug reaching the fetus.
Journal ArticleDOI
Measurement of drugs in neonatal hair; a window to fetal exposure.
TL;DR: In this article, the presence of drugs (e.g., cocaine) or environmental toxins such as nicotine and benzoylecgonine in the hair of newborns was measured.
Journal ArticleDOI
P450 oxidoreductase *28 (POR*28) and tacrolimus disposition in pediatric kidney transplant recipients--a pilot study.
Violette M G J Gijsen,Ron H. N. van Schaik,Offie P. Soldin,Steven J. Soldin,Irena Nulman,Gideon Koren,Saskia N. de Wildt +6 more
TL;DR: In this small cohort of pediatric kidney transplant recipients, POR*28 genotype seems to explain part of the variability found in tacrolimus disposition, in addition to age and CYP3A5 genotype.